Docetaxel Anhydrous is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Curae Pharma360 Inc.. The primary component is Docetaxel Anhydrous.
| Product ID | 73358-210_35fab376-0ff9-4227-b780-4bf3ffd0bccc |
| NDC | 73358-210 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Docetaxel Anhydrous |
| Generic Name | Docetaxel Anhydrous |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-10-17 |
| Marketing Category | ANDA / |
| Application Number | ANDA209634 |
| Labeler Name | Curae Pharma360 Inc. |
| Substance Name | DOCETAXEL ANHYDROUS |
| Active Ingredient Strength | 10 mg/mL |
| Pharm Classes | Microtubule Inhibition [PE], Microtubule Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-10-17 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 69097-369 | Docetaxel Anhydrous | Docetaxel Anhydrous |
| 69097-371 | Docetaxel Anhydrous | Docetaxel Anhydrous |
| 69097-372 | Docetaxel Anhydrous | Docetaxel Anhydrous |
| 71288-144 | Docetaxel anhydrous | Docetaxel anhydrous |
| 71288-143 | Docetaxel anhydrous | Docetaxel anhydrous |
| 0409-0016 | Docetaxel | DOCETAXEL ANHYDROUS |
| 0409-0201 | Docetaxel | DOCETAXEL ANHYDROUS |
| 0409-1732 | Docetaxel | DOCETAXEL ANHYDROUS |
| 0409-2026 | Docetaxel | DOCETAXEL ANHYDROUS |
| 0409-7870 | Docetaxel | DOCETAXEL ANHYDROUS |
| 25021-245 | Docetaxel | Docetaxel Anhydrous |
| 50742-428 | DOCETAXEL | DOCETAXEL ANHYDROUS |
| 50742-431 | DOCETAXEL | DOCETAXEL ANHYDROUS |
| 50742-463 | DOCETAXEL | DOCETAXEL ANHYDROUS |
| 67457-531 | Docetaxel | DOCETAXEL ANHYDROUS |
| 67457-532 | Docetaxel | DOCETAXEL ANHYDROUS |
| 67457-533 | Docetaxel | DOCETAXEL ANHYDROUS |